RhumbLine Advisers’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-98,339
Closed -$17M 3199
2015
Q1
$17M Buy
98,339
+7,810
+9% +$1.35M 0.05% 351
2014
Q4
$10.4M Buy
90,529
+1,197
+1% +$138K 0.03% 482
2014
Q3
$14M Sell
89,332
-2,851
-3% -$445K 0.04% 383
2014
Q2
$11.4M Sell
92,183
-4,427
-5% -$546K 0.03% 450
2014
Q1
$10M Sell
96,610
-1,942
-2% -$201K 0.03% 504
2013
Q4
$8.86M Sell
98,552
-7,619
-7% -$685K 0.03% 533
2013
Q3
$7.1M Buy
106,171
+37,012
+54% +$2.48M 0.02% 645
2013
Q2
$4.58M Buy
+69,159
New +$4.58M 0.01% 813